期刊文献+

食管鳞癌组织中葡萄糖转运蛋白-1表达的临床意义

Expression of Glucotransporter-1 in Different Development Stages of Esophageal Squamous Carcinoma
下载PDF
导出
摘要 目的探讨葡萄糖转运蛋白-1(GLUT-1)的表达与食管鳞癌发生、发展的关系。方法对95例食管癌患者的手术切除标本及胃镜活检标本采用免疫组化S-P法检测GLUT-1表达水平。结果GLUT-1在食管鳞癌组织、癌旁不典型增生组织及正常食管组织中的阳性表达率、不同浸润程度时的表达率、临床病理分型的表达率、淋巴结转移的表达率之间差异有统计学意义(P<0.05)。结论GLUT-1在食管鳞癌的发生、发展中具有重要作用,有可能成为临床食管鳞癌诊断和判断预后的一个重要指标。 Objective To study the correlation of the expression of glucose transporter-1 (GLUT-1) and the different development stages of esophageal squamous carcinoma. Methods The samples were obtained from 95 patients with esophageal carcinoma. The esophageal tissue specimen was taken from operation or biopsy and the expression of GLUT-1 was detected by S- P immunohistochemical staining. The resuits were analyzed with chi- square test and exact probability. Results There was statistical significance in the differences of GLUT- 1 expression among normal esophageal tissue, atypical paracancerous hyperplasia, esophageal squamous carcinoma tissue, different infiltration degrees and pathologic types, and lymph nodes metastasis of esophageal squamous carcinoma (P 〈 0. 05). Conclusion GLUT-1 plays an important role in the occurrence and progress of esophageal squamous carcinoma and may become a very important index for diagnosis, healing and prognosis assess of esophageal squamous carcinoma.
出处 《中国药业》 CAS 2008年第21期18-19,共2页 China Pharmaceuticals
关键词 食管鳞癌 免疫组化 葡萄糖转运蛋白-1 immunohistochemistry esophageal squamous carcinoma glucose transporter- 1
  • 相关文献

参考文献12

  • 1黄受方,廖松林.重视WHO肿瘤组织学新分类[J].中华病理学杂志,2002,31(2):101-103. 被引量:14
  • 2Ravazoula P, Batistatou A, Aletra C, et al. Immunhistochemical expression of glucose transporter GLUTI and cyclin D1 in breast carcino-mas cell negative lymph nodes[J] .Eur J Gynaecol Oncol, 2003, 24(6): 544 - 546.
  • 3Cohen NA, Lai SY, Ziober AF, et al. Dysregulation of hypoxia factor 1 alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential [ J ]. Laryngoscope, 2004, 114 (3) : 418 - 423.
  • 4Hatashi M, Sakata M, Takeda T, et al. Induction of glucose transporter 1 expression through hypoxia-inducible factor 1 alpha under hypoxic conditions in trophoblast - derived cells [ J ]. J Endocrinol, 2005, 183 ( 1 ) : 145 - 154.
  • 5Xu RH, Pelicano H, Zhou Y, et al. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia[J].Cancer Res, 2005, 65(2): 613 -621.
  • 6Fogelholm R, Murros K, Rissanen A, et al. Long termsurvival after primary intracerebral haemorrhage: a retrospective population based study [J]. J Neurol Neurosurg Psychiatry, 2005, 76( 11 ): 1534 - 1 538.
  • 7Wong L, Deb TB, Thompson SA, et al. Differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling[J].J Biol Chem, 1999, 274(13): 8 900 -8 909.
  • 8Shi W, Fan H, Shum L, et al. The tetraspanin CD9 associated with transmembrane TGF-alpha induced EGF receptor activation and cell proliferation [ J ]. J Cell Biol, 2000, 148 (3) : 591 - 602.
  • 9Lasa M. Brook M, Saklatvala J, et al. D exame thasone destabilizes eyclooxygenase-2 mRNA by inhibiting mitogen-activated protein kinase p38[J]. Mol Cell Biol, 2007, 2( 1 ): 771 - 780.
  • 10Higshi, Skogsberg J, Hamsten A, et al. PPAR delta activation induces COX- 2 gene expression and cell proliferation in human heap to cellular carcinoma cells[J] .Biochem Biophys Res Commun, 2005, 308 (2): 361 -368.

二级参考文献14

  • 1Sakashita M,Aoyama N,Minami R,et at.Glut 1 expression in T1 and T2 stage colorectal carcinomas:its relationship to clinicopathological features[J].Eur J Cancer,2001,37 (2):204
  • 2Guo YS,Narayan S,Yallampalli C,et al.Characterization of insulinlike growth factor I receptors in human colon cancer[J].Gastroenterology,1992,102 (4 Pt 1):1 101
  • 3Kalir T,Wang BY,Goldfischer M,et al.Immunohistochemical staining of Glutl in benign,borderline,and malignant ovarian epithlia[J].Cancer,2002,94 (4):1 078
  • 4Reissere E,Eichhorn K,Herold-Mende C.Glucose uptake in malignant tumors of head and neck[J].HNO,1999,47(8):712
  • 5Mushot TJ,Musholt PB,Dehdashti F,et al.Evaluation of fluorodeoxyglucose-positron emission tomographic scaning and association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma clinical molecular study[J].Surgery,1997,122(6):1 049
  • 6Nagase Y,Takata K,Myriyama N,et al.Immunohistochemical location of glucose transporters in human renal cell carcinoma[J].J Urol,1995,153(3 Pt 1):798
  • 7Kunkel M,Reichert TE,Benz P,et al.Overexpression of Glutl and increased glucose metabolism in tumors are associated with the poor prognosis in patients with oral squamous cell carcinoma[J].Cancer,2003,97 (4):1 015
  • 8Wang BY,Kalir T,Sabo E,et al.Immunohistochemical staining of GLUT1 in benign,hyperplastic,and malignant endometrial epithelia[J].Cancer,2000,88(12):2 774
  • 9Di Giovanni J,Bol Dk,Wilker E,et al.Constitutive expression of insulin-like growth factor-1 in epithermal basal cells of transgenic mice leads to spontaneous tumor promotion[J].Cancer Res,2000,60(6):1 561
  • 10毛一雷.胰岛素样生长因子预测和诊断肿瘤的新手段[J].中国实用外科杂志,1999,19(12):752-753. 被引量:9

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部